Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial

Table 3

Comparison of immune function after treatment (‾x ± s).

Group	n	CD3^+ (%)	CD4^+ (%)	CD8^+ (%)	CD4^+/CD8^+
SG	37	62.31 ± 5.29	42.56 ± 4.19	25.71 ± 3.62	1.57 ± 0.18
RG	37	53.62 ± 5.17	33.18 ± 3.84	31.21 ± 3.41	1.14 ± 0.14
t		7.146	10.039	6.727	11.470
		<0.001	<0.001	<0.001	<0.001